Patents by Inventor Kerry A. Bradley

Kerry A. Bradley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240139513
    Abstract: The present technology provides systems and methods for directly suppressing nerve cells by delivering electrical stimulation having relatively long pulse widths and at amplitudes below an activation threshold of the nerve cells. For example, some embodiments include delivering a therapy signal having individual pulses with pulse widths of between about 5 ms and 100 ms. Directly suppressing the nerve cells is expected to reduce the transmission of pain signals.
    Type: Application
    Filed: October 13, 2023
    Publication date: May 2, 2024
    Inventors: Kerry Bradley, Dongchul Lee
  • Publication number: 20240001121
    Abstract: Stimulation for treating sensory deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 200 Hz to 100 kHz.
    Type: Application
    Filed: June 29, 2023
    Publication date: January 4, 2024
    Inventors: Dongchul Lee, Kerry Bradley, Kwan Yeop Lee
  • Patent number: 11819693
    Abstract: The present technology provides systems and methods for directly suppressing nerve cells by delivering electrical stimulation having relatively long pulse widths and at amplitudes below an activation threshold of the nerve cells. For example, some embodiments include delivering a therapy signal having individual pulses with pulse widths of between about 5 ms and 100 ms. Directly suppressing the nerve cells is expected to reduce the transmission of pain signals.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: November 21, 2023
    Assignee: Nevro Corp.
    Inventors: Kerry Bradley, Dongchul Lee
  • Publication number: 20230271016
    Abstract: Systems and methods for treating congestive heart failure with high frequency stimulation are disclosed. A representative method for treating a patient includes applying an electrical signal having a frequency of from about 1 kHz to about 100 kHz to the patient via a treatment system that includes a signal delivery element in electrical communication with the patient's vagus nerve at a portion of the vagus nerve located at or proximate to the anterior interventricular junction of the patient's heart. The method can further include automatically detecting at least one physiological parameter of the patient, automatically determining at least one of an ejection fraction of the patient's heart and a correlate of the ejection fraction based on the detected parameter, and automatically adjusting the applied signal based on the determined ejection fraction.
    Type: Application
    Filed: January 31, 2023
    Publication date: August 31, 2023
    Inventors: James R. Thacker, Kerry Bradley
  • Publication number: 20230248973
    Abstract: High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction and/or motor dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 1.5 kHz to 100 kHz.
    Type: Application
    Filed: April 6, 2023
    Publication date: August 10, 2023
    Inventors: Jeyakumar Subbaroyan, Kerry Bradley, Dongchul Lee
  • Publication number: 20230241388
    Abstract: High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction and/or motor dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 1.5 kHz to 100 kHz.
    Type: Application
    Filed: April 6, 2023
    Publication date: August 3, 2023
    Inventors: Jeyakumar Subbaroyan, Kerry Bradley, Dongchul Lee
  • Patent number: 11596798
    Abstract: Systems and methods for treating congestive heart failure with high frequency stimulation are disclosed. A representative method for treating a patient includes applying an electrical signal having a frequency of from about 1 kHz to about 100 kHz to the patient via a treatment system that includes a signal delivery element in electrical communication with the patient's vagus nerve at a portion of the vagus nerve located at or proximate to the anterior interventricular junction of the patient's heart. The method can further include automatically detecting at least one physiological parameter of the patient, automatically determining at least one of an ejection fraction of the patient's heart and a correlate of the ejection fraction based on the detected parameter, and automatically adjusting the applied signal based on the determined ejection fraction.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: March 7, 2023
    Assignee: Nevro Corp
    Inventors: James R. Thacker, Kerry Bradley
  • Patent number: 11590352
    Abstract: Systems and methods for treating a patient's pain using ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods are disclosed. A representative method for treating a patient includes positioning an implantable signal delivery device proximate to a target location at or near the patient's spinal cord, and delivering an electrical therapy signal to the target location via the implantable signal delivery device, wherein the electrical therapy signal has a frequency in a frequency range of from about 1 kHz to about 100 kHz, and wherein the frequency is increased or decreased from a first value to a second value during delivery.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: February 28, 2023
    Assignee: Nevro Corp.
    Inventors: Dongchul Lee, Kerry Bradley, Kwan Yeop Lee
  • Publication number: 20220401730
    Abstract: The present technology provides systems and methods for directly suppressing nerve cells by delivering electrical stimulation having relatively long pulse widths and at amplitudes below an activation threshold of the nerve cells. For example, some embodiments include delivering a therapy signal having individual pulses with pulse widths of between about 5 ms and 100 ms. Directly suppressing the nerve cells is expected to reduce the transmission of pain signals.
    Type: Application
    Filed: June 10, 2022
    Publication date: December 22, 2022
    Inventors: Dongchul Lee, Kerry Bradley
  • Publication number: 20220379116
    Abstract: The present technology is directed generally to spinal cord modulation and associated systems and methods for treating pain and other patient conditions. In particular, the present technology includes modified high frequency neuromodulation signals and administration patterns.
    Type: Application
    Filed: May 25, 2022
    Publication date: December 1, 2022
    Inventors: Dongchul Lee, Kerry Bradley
  • Publication number: 20220362565
    Abstract: Tissue stimulation systems generally include a pulse generating device for generating electrical stimulation pulses, at least one implanted electrode for delivering the electrical stimulation pulses generated by the pulse generating device, and a programmer capable of communicating with the pulse generating device. Stimulation pulses may be defined by several parameters, such as pulse width and amplitude. In methods of stimulating the tissue with the stimulation system, a user may adjust one of the parameters such as pulse width. The programmer may automatically adjust the pulse amplitude in response to the change in pulse width in order to maintain a substantially constant effect of the stimulation pulses.
    Type: Application
    Filed: July 19, 2022
    Publication date: November 17, 2022
    Inventors: James R. Thacker, Harold Haut, Robert Nathan, David K.L. Peterson, Kerry Bradley
  • Patent number: 11497917
    Abstract: A method of stimulating nerve tissue, a tissue stimulation system, and an external control device are provided. The method, system, and control device causes an electrical stimulus to be applied to at least one electrode adjacent the nerve tissue of a patient. The applied electrical stimulus comprises a plurality of pulses defined by a pulse width value and an amplitude value. The pulse amplitude value is increased (e.g., manually), and the pulse width value is automatically decreased in response to increasing the pulse amplitude value in a manner that increases the intensity of the applied electrical stimulus. Alternatively, the pulse width value may be decreased (e.g., manually), and the pulse amplitude value automatically increased in response to decreasing the pulse width value in a manner that increases the intensity of the applied electrical stimulus.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: November 15, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Kerry Bradley, Bradley Lawrence Hershey, Dongchul Lee
  • Publication number: 20220355106
    Abstract: A method, electrical tissue stimulation system, and programmer for providing therapy to a patient are provided. Electrodes are placed adjacent tissue (e.g., spinal cord tissue) of the patient, electrical stimulation energy is delivered from the electrodes to the tissue in accordance with a defined waveform, and a pulse shape of the defined waveform is modified, thereby changing the characteristics of the electrical stimulation energy delivered from the electrode(s) to the tissue. The pulse shape may be modified by selecting one of a plurality of different pulse shape types or by adjusting a time constant of the pulse shape.
    Type: Application
    Filed: July 19, 2022
    Publication date: November 10, 2022
    Inventors: Dongchul Lee, Michael A. Moffitt, Christopher Ewan Gillespie, Kerry Bradley
  • Patent number: 11439831
    Abstract: Tissue stimulation systems generally include a pulse generating device for generating electrical stimulation pulses, at least one implanted electrode for delivering the electrical stimulation pulses generated by the pulse generating device, and a programmer capable of communicating with the pulse generating device. Stimulation pulses may be defined by several parameters, such as pulse width and amplitude. In methods of stimulating the tissue with the stimulation system, a user may adjust one of the parameters such as pulse width. The programmer may automatically adjust the pulse amplitude in response to the change in pulse width in order to maintain a substantially constant effect of the stimulation pulses.
    Type: Grant
    Filed: September 30, 2019
    Date of Patent: September 13, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: James R. Thacker, Harold Haut, Robert Nathan, David K. L. Peterson, Kerry Bradley
  • Patent number: 11420065
    Abstract: A method, electrical tissue stimulation system, and programmer for providing therapy to a patient are provided. Electrodes are placed adjacent tissue (e.g., spinal cord tissue) of the patient, electrical stimulation energy is delivered from the electrodes to the tissue in accordance with a defined waveform, and a pulse shape of the defined waveform is modified, thereby changing the characteristics of the electrical stimulation energy delivered from the electrode(s) to the tissue. The pulse shape may be modified by selecting one of a plurality of different pulse shape types or by adjusting a time constant of the pulse shape.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: August 23, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Dongchul Lee, Michael A. Moffitt, Christopher Ewan Gillespie, Kerry Bradley
  • Patent number: 11376435
    Abstract: A method of treating an ailment suffered by a patient using one or more electrodes adjacent spinal column tissue of the patient, comprises delivering electrical modulation energy from the one or more electrodes to the spinal column tissue in accordance with a continuous bi-phasic waveform having a positive phase and a negative phase, thereby modulating the spinal column tissue to treat the ailment. An implantable electrical modulation system, comprises one or more electrical terminals configured for being coupled to one or more modulation leads, output modulation circuitry capable of outputting electrical modulation energy to the electrical terminal(s) in accordance with a continuous bi-phasic waveform, and control circuitry configured for modifying a shape of the continuous bi-phasic waveform, thereby changing the characteristics of the electrical modulation energy outputted to the electrode(s).
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: July 5, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Kerry Bradley, Rafael Carbunaru, Dongchul Lee, Michael A. Moffitt, Christopher Ewan Gillespie
  • Publication number: 20220168572
    Abstract: High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods. A representative method includes addressing the patient's somatosensory dysfunction and/or motor dysfunction, resulting from neuropathy and/or spinal cord injury, by directing an electrical therapy signal to the patient's spinal cord region, the therapy signal having a frequency in a frequency range from 1.5 kHz to 100 kHz.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 2, 2022
    Inventors: Jeyakumar Subbaroyan, Kerry Bradley, Dongchul Lee
  • Patent number: 11318310
    Abstract: Electrical stimulation, including high frequency stimulation, for altering autonomic functions, and associated systems and methods are disclosed. A representative method includes directing an electrical signal to a target tissue at (a) a ventral region of the patient's spinal canal, (b) a sympathetic chain structure, or (c) both (a) and (b), at a frequency in a range from 1 kHz to 100 kHz, and an amplitude that does not generate an objectionable, patient-detectable sensation.
    Type: Grant
    Filed: October 25, 2016
    Date of Patent: May 3, 2022
    Assignee: Nevro Corp.
    Inventor: Kerry Bradley
  • Patent number: 11135424
    Abstract: In various examples, an apparatus is configured for targeted placement of a lead body within a patient. The lead body includes at least one distal electrode. The apparatus includes a needle including a lumen sized to accommodate the lead body within the lumen. A stylet is insertable within the needle, wherein at least one of the needle and the stylet includes at least one imageable marker corresponding in size, shape, and location to the at least one distal electrode of the lead body. The at least one imageable marker is configured to allow a user to determine placement within the patient of the at least one distal electrode of the lead body prior to implantation of the lead body within the patient.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: October 5, 2021
    Assignee: Greatbatch Ltd.
    Inventors: Kerry Bradley, Leslie I. Halberg
  • Patent number: 11123565
    Abstract: Systems and methods for treating neurodegenerative disorders with high frequency stimulation are disclosed. A representative method for treating a patient includes applying an electrical signal to the patient via a treatment system that includes a signal delivery element positioned at or within a white matter of the patient's brain, spinal cord, or both, the electrical signal having a frequency of from about 1.5 kHz to about 100 kHz.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: September 21, 2021
    Assignee: Nevro Corp.
    Inventors: James R. Thacker, Kerry Bradley, Dongchul Lee